cabergoline has been researched along with Pregnancy in 150 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (2.00) | 18.7374 |
| 1990's | 28 (18.67) | 18.2507 |
| 2000's | 41 (27.33) | 29.6817 |
| 2010's | 56 (37.33) | 24.3611 |
| 2020's | 22 (14.67) | 2.80 |
| Authors | Studies |
|---|---|
| Shi, H; Wu, D; Yu, T; Yu, Y; Zhai, J | 1 |
| Karakus, C; Ozyurt, R; Turktekin, N | 1 |
| Witwit, SJ | 1 |
| Inder, WJ; Jang, C | 1 |
| Bauersachs, J; Berliner, D; Erschow, S; Haebel, L; Hilfiker-Kleiner, D; Koenig, T; Mueller, JH; Pfeffer, TJ; Ricke-Hoch, M; Scherr, M; Talbot, SR; Yalman, KC; Zwadlo, C | 1 |
| Hayashi, T; Higuchi, Y; Hirayama, A; Ichibori, Y; Iwai, S; Makino, N; Minamiguchi, H; Mitake, A; Mori, N; Shiba, M; Shibuya, Y | 1 |
| Bruehlman, RD; McKittrick, C; Winters, S | 1 |
| Auriemma, RS; Colao, A; Garifalos, F; Pirchio, R; Pivonello, C; Pivonello, R | 1 |
| Cecenarro, LA; Fux-Otta, C; Murillo, NB; Ramacciotti, CF | 2 |
| Miller, KK; Tritos, NA | 1 |
| Blumenthal, PD; Cahill, EP; Henkel, A; Johnson, SA; Reeves, MF; Shaw, KA | 1 |
| Atabay, F; Ateş, Ç; Dilbaz, B; Ergani, SY | 1 |
| Farrant, MT; Gunn, AJ; Milsom, SR; O'Sullivan, SM; Ogilvie, CM | 1 |
| Abucham, J; Boguszewski, CL; Bronstein, MD; Bueno, CB; Castro, M; Czepielewski, MA; Elias, PCL; Fontana, MLC; Francisco, RPV; Gadelha, MR; Garmes, HM; Glezer, A; Lyra, R; Marques, C; Martins, MRA; Musolino, NRC; Nazato, D; Nunes-Nogueira, VS; Portes, ES; Quidute, ARP; Ribeiro-Oliveira, A; Sant' Anna, BG; Vilar, L | 1 |
| Baba, K; Hayashi, N; Huang, H; Ichinose, S; Itaya, Y; Matsunaga, S; Narita, T; Ono, Y; Saitoh, M; Samejima, K; Seki, H; Takai, Y | 1 |
| Arce, JC; Bagger, YZ; Galliano, D; Herraiz, S; Pellicer, A; Pellicer, N | 1 |
| Hart, RJ; Mourad, SM; Tang, H; Wang, A; Zhai, SD | 1 |
| Biermasz, NR; Chanson, P; Jorgensen, JOL; Kuhn, E; Weinreich, AA | 1 |
| Franchi, GA; Herskin, MS; Jensen, MB; Larsen, M; Tucker, CB | 1 |
| Ach, K; Ach, T; Ben Abdelkrim, A; Chaieb, M; Elfekih, H; Hasni, Y; Kacem, M; Khaldi, S; Maaroufi, A; Saad, G | 1 |
| Elshaer, HS; Farouk, M; Fouda, UM; Hanafy, A; Mehrem, WM; Nabil, H; Youssef, GG; Youssef, MA | 1 |
| Abdelsalam, EA; Elmahdy, M; Maghraby, HA | 1 |
| Amso, NN; D'Angelo, A; Hassan, R | 1 |
| Araujo, B; Belo, S; Carvalho, D | 1 |
| Deepak, DS; Lee, KO; Sek, KS | 1 |
| Shimatsu, Y | 1 |
| Bassiouny, YA; Bayoumi, YA; Dakhly, DMR; Gouda, HM; Hassan, AA; Salaheldin, NM | 1 |
| Čehić, E; Franulić, D; Grgić, F; Kasum, M; Lila, A; Orešković, S; Vujić, G | 1 |
| Hefzy, E; Seyam, E | 1 |
| Celik, H; Celik, S; Hatirnaz, ES; Hatirnaz, S; Soyer-Calıskan, C; Tosun, M | 1 |
| Ikeda, H; Tominaga, T; Watanabe, K; Yoshimoto, T | 1 |
| Chen, HJ; Hsieh, BC; Huang, LW; Huang, MZ; Hwang, JL; Lin, YH; Seow, KM; Tzeng, CR | 1 |
| Bai, CH; Chen, HJ; Hsieh, BC; Huang, LW; Hwang, JL; Lin, YH; Seow, KM; Tzeng, CR | 1 |
| Bozdag, G; Esinler, I; Karakocsokmensuer, L | 1 |
| Ehsanipoor, RM; Woo, I | 1 |
| Andrés, M; Expósito, A; Matorras, R; Mendoza, R; Pijoan, JI; Prieto, B | 1 |
| Abucham, J; Boguszewski, C; Dias, M; Gadelha, M; Kasuki, L; Musolino, N; Vieira, JG | 1 |
| Leitao, VM; Martins, WP; Moroni, RM; Nastri, CO; Seko, LM | 1 |
| Du, Y; Lin, XM; Ma, YS; Ni, J; Tang, YY; Zhou, J | 1 |
| Figueroa-Núñez, C; González, E; Gutierrez, M; Hernán Martínez, J; Mangual-García, M; Mansilla-Letelier, P; Miranda, Mde L; Palermo-Garofalo, C; Sánchez, A; Santiago, M; Torres, O; Trinidad, R | 1 |
| Bronstein, MD; Glezer, A | 1 |
| Schäfer-Somi, S; Schwendenwein, I; Sontas, BH | 1 |
| Eglash, A | 1 |
| Angelova, M; Kacarova, P; Kozovski, G | 1 |
| Cámara Gómez, R; Del Olmo García, M; Merino Torres, JF; Querol Ripoll, R; Simal Julián, JA | 1 |
| Couldwell, WT; Eloy, JA; Liu, JK; Wong, A | 1 |
| Apaydın, N; Cengiz, H; Eskicioğlu, F; Genç, M; Şahin, N; Sivrikoz, ON; Töz, E; Turan, GA | 1 |
| Elsetohy, KA; Elshaer, HS; Fouda, UM; Hammad, BE; Sayed, AM; Shaban, MM; Youssef, MA | 1 |
| Ahmad, MS; Nakhleh, A; Pearl, IW; Reut, M; Saiegh, L; Shechner, C | 1 |
| Araujo Júnior, E; Carvalho, JS; Carvalho, RC; Costa Carvalho, FH; Feitosa, FE; Melo, MA; Peixoto, AB | 1 |
| Fett, JD | 1 |
| Beshyah, SA; Chentli, F; El-Fikki, M; Hamrahian, A; Jambart, S; Khalil, AB; Raef, H; Sherif, IH | 1 |
| Hart, RJ; Mourad, S; Tang, H; Zhai, SD | 1 |
| Bhadada, SK; Bhansali, A; Rastogi, A | 1 |
| Dhanjal, MK; Knight, M; Lambert, K; McCance, DR; Rees, K; Seed, PT; Williamson, C | 1 |
| Brown, J; Farquhar, C; Mourad, S | 1 |
| Banerjee, A; Hatfield, EC; Martin, NM; Meeran, K; Tan, T; Williamson, C; Wynne, K | 1 |
| Jin, ZM | 1 |
| Acharya, SV; Bandgar, TR; Gopal, RA; Joshi, SR; Menon, PS; Shah, NS | 1 |
| Bouma, BJ; de Jong, JS; Rietveld, K; van Lochem, LT | 1 |
| Kharlip, J; Salvatori, R; Wand, GS; Yenokyan, G | 1 |
| England, GC; Freeman, SL; Russo, M | 1 |
| Ballabio, R; Gelli, D; Milani, C; Mollo, A; Perin, S; Romagnoli, S; Stelletta, C | 1 |
| Arias, D; Barrena, JP; Blanco, PG; Corrada, Y; Gobello, C; Rube, A | 1 |
| Einspanier, A; Günzel-Apel, AR; Höftmann, T; Hoppen, HO; Knijn, HM; Meyer-Lindenberg, A; Mischke, R; Nottorf, S; Politt, E | 1 |
| Albuquerque, JL; Azevedo, MF; Boguszewski, CL; Bronstein, MD; Casulari, LA; de Oliveira, AR; Dos Santos Faria, M; Gadelha, MR; Montenegro, RM; Musolino, NR; Naves, LA; Pinho Barbosa, FR; Ramos, AJ; Serfaty, FM; Vilar, L | 1 |
| Boissevain, I | 1 |
| Amano, K; Hori, T; Izumi, S; Kawamata, T; Makino, R; Miki, N; Okada, Y; Ono, M; Seki, T; Takano, K | 1 |
| Klibanski, A | 1 |
| Marinov, B | 1 |
| Arioz, DT; Dilek, H; Koken, T; Saylan, A; Saylan, F; Yilmazer, M | 1 |
| Bernard, P; Hubinont, C; Lebbe, M; Maiter, D | 1 |
| Bahceci, M; Sismanoglu, A; Ulug, U | 1 |
| Molitch, ME | 2 |
| Alfieri, A; Ballarino, MC; Boero, L; Chervin, A; Danilowicz, K; Diez, S; Fainstein-Day, P; García-Basavilbaso, N; Glerean, M; Gollan, V; Guitelman, M; Katz, D; Loto, MG; Mallea-Gil, MS; Manavela, M; Rogozinski, AS; Servidio, M; Stalldecker, G; Vitale, NM | 1 |
| Bourdel, N; Delabaere, A; Jardon, K; Pouly, JL; Tran, X | 1 |
| Agaoglu, AR; Aslan, S; Colak, A; Emre, B; Gultiken, N; Kaya, D; Kucukaslan, I; Mulazımoglu, BS; Schäfer-Somi, S | 1 |
| Akutsu, H; Matsumura, A; Sato, H; Takano, S; Watanabe, S | 1 |
| Arabipoor, A; Aziminekoo, E; Bahmanabadi, A; Chehrazi, M; Hafezi, M; Tehraninejad, ES | 1 |
| Hart, RJ; Hu, Y; Hunter, T; Sheng, X; Tang, H; Zhai, SD | 1 |
| Maiter, D; Primeau, V | 1 |
| Nak, D; Nak, Y; Simsek, G | 1 |
| Berardini, A; Biagini, E; Graziosi, M; Pazzi, C; Rapezzi, C; Rosmini, S | 1 |
| Peregrin Abad, E; Salinas Botrán, A; Urgelés Puértolas, D | 1 |
| Shaltout, A; Shohyab, A; Youssef, MA | 1 |
| Shahzad, H; Sheikh, A; Sheikh, L | 1 |
| Auriemma, RS; Colao, A; Di Sarno, A; Gasperi, M; Grasso, LF; Guerra, E; Perone, Y; Pivonello, R | 1 |
| Liu, C; Tyrrell, JB | 1 |
| DeLiberto, TJ; Jöchle, W; Kimball, B; Seglund, A | 1 |
| Calda, P; Pavlista, D; Zivný, J | 1 |
| Gabai, G; Marinelli, L; Mollo, A; Rota, A; Vincenti, L | 1 |
| Arbeiter, K; Aslan, S; Erünal-Maral, N; Findik, M; Handler, J; Yüksel, N | 1 |
| Couldwell, WT; Liu, JK | 1 |
| Trifonov, I | 1 |
| Brooks, PL; Vella, ET; Wynne-Edwards, KE | 1 |
| Abs, R; Verhelst, J | 1 |
| Adamo, V; Manno, M; Marchesan, E; Tomei, F | 1 |
| Crosignani, PG | 1 |
| Bronstein, MD | 1 |
| Günzel-Apel, AR; Hoeftmann, T; Meyer-Lindenberg, A; Politt, E; Schoon, HA; Steiger, K | 1 |
| Kanzato, N; Murao, H; Nishihira, T; Takara, H | 1 |
| Ak, K; Bacinoglu, S; Cangul, IT; Cirit, U; Kaya, HH; Taş, M | 1 |
| Alvarez, C; Fernández-Sánchez, M; Gómez, R; Martí-Bonmatí, L; Novella-Maestre, E; Pellicer, A; Sanz, R; Simón, C | 1 |
| Ciraru-Vigneron, N; Laloi-Michelin, M; Meas, T | 1 |
| Aboulghar, MA | 1 |
| Aksoy, OA; Aslan, S; Beceriklisoy, HB; Einspanier, A; Hoppen, HO; Schäfer-Somi, S | 1 |
| Abs, R; Bárcena, DG; Chanson, P; Colao, A; Kleinberg, DL; Paulus, W | 1 |
| Alonso-Muriel, I; Alvarez, C; Bellver, J; Crespo, J; García, G; Pellicer, A; Simón, C | 1 |
| Bevan, JS; Davis, JR | 1 |
| Ciccarelli, E; D'Alberton, A; Falsetti, L; Ferrari, C; Fioretti, P; Giordano, G; L'Hermite, M; Piscitelli, G; Polli, A; Webster, J | 1 |
| Donnay, I; Onclin, K; Silva, LD; Verstegen, JP | 2 |
| Fraser, RB; Jones, TH | 1 |
| Ajossa, S; Depau, GF; Guerriero, S; Mais, V; Melis, GB; Paoletti, AM | 1 |
| Delahaut, P; Ectors, F; Onclin, K; Silva, LD; Verstegen, JP; Wouters-Ballman, P | 1 |
| Jöchle, M; Jöchle, W | 1 |
| Delgrange, E; Donckier, J; Maiter, D | 1 |
| Webster, J | 3 |
| Onclin, K; Verstegen, JP | 2 |
| Koide, SS; Negishi, H | 1 |
| Jeukenne, P; Verstegen, J | 1 |
| Onclin, K; Verstegen, J | 1 |
| Arosio, M; Biella, O; Faglia, G; Gambino, G; Muratori, M; Romano, C | 1 |
| Bertagna, A; Camanni, F; Camanni, M; Cammarota, T; Ciccarelli, E; Cirillo, S; Gaia, D; Grottoli, S; Razzore, P | 1 |
| Armentano, G; Bracco, PL; Pellegrini, A; Sugliano, GC; Tornatore, GP | 1 |
| Hettling, P | 1 |
| Hearn, CM; Renfree, MB; Shaw, G; Short, RV | 1 |
| Krack, P; Mönig, H | 1 |
| Almoto, B; Cannavò, S; Curtò, L; Squadrito, S; Trimarchi, F; Vieni, A | 1 |
| Abs, R; Beckers, A; Coremans, P; Lamberigts, G; Mahler, C; Maiter, D; Mockel, J; Petrossians, P; Raftopoulos, C; Stevenaert, A; van den Bruel, A; Vandeweghe, M; Velkeniers, B; Verhelst, J; Verlooy, J | 1 |
| Abs, R; Berwaerts, J; Mahler, C; Verhelst, J | 1 |
| Concannon, PW; Onclin, K; Silva, LD; Verstegen, JP | 1 |
| Annunziato, L; Colao, A; Lombardi, G | 1 |
| Jalkanen, L; Marks, CA; Savolainen, R; Short, RV | 1 |
| De Santis, L; Doldi, N; Ferrari, A; Marelli, G; Marsiglio, E; Papaleo, E; Rofena, S | 1 |
| Bozhinova, S; Penkov, V; Porozhanova, V | 1 |
| Jöchle, W; Lengwinat, T; Meyer, HH | 1 |
| Marks, CA | 1 |
| Colao, A; di Sarno, A; di Somma, C; Lombardi, G; Pivonello, R | 1 |
| Castex, G; Corrada, Y; Gobello, C | 1 |
| Brzozowski, M; Clark, M; Marks, CA; Zurek, H | 1 |
| Arbeiter, K; Ballabio, R; D'Ver, AS; Jöchle, W; Post, K | 1 |
| Beneventi, F; Fioretti, P; Gambacciani, M; Mais, V; Melis, GB; Paoletti, AM | 1 |
| Baroldi, P; Beneventi, F; Fioretti, P; Gambacciani, M; Mais, V; Melis, GB; Paoletti, AM | 1 |
29 review(s) available for cabergoline and Pregnancy
| Article | Year |
|---|---|
Comparison of the Effectiveness of Various Medicines in the Prevention of Ovarian Hyperstimulation Syndrome: A Network Meta-Analysis of Randomized Controlled Trials.
Topics: Cabergoline; Female; Humans; Network Meta-Analysis; Ovarian Hyperstimulation Syndrome; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic | 2022 |
Treatment of Prolactinoma.
Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Female; Humans; Pituitary Neoplasms; Pregnancy; Prolactinoma; Treatment Outcome | 2022 |
Approach to the Patient With Prolactinoma.
Topics: Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hypogonadism; Male; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma | 2023 |
Diagnosis and Management of Pituitary Adenomas: A Review.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Bromocriptine; Cabergoline; Child; Female; Human Growth Hormone; Humans; Hypopituitarism; Pituitary Neoplasms; Pregnancy; Prolactinoma | 2023 |
Use of dopamine agonists to target angiogenesis in women with endometriosis.
Topics: Cabergoline; Dopamine Agonists; Endometriosis; Endometrium; Female; Humans; Pregnancy; Vascular Endothelial Growth Factor A | 2021 |
Dopamine agonists for preventing ovarian hyperstimulation syndrome.
Topics: Abortion, Spontaneous; Administration, Oral; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Fertilization in Vitro; Humans; Live Birth; Ovarian Hyperstimulation Syndrome; Placebos; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Sperm Injections, Intracytoplasmic | 2021 |
Apoplexy of microprolactinomas during pregnancy: report of five cases and review of the literature.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Female; Humans; Pituitary Apoplexy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Prolactinoma; Tumor Burden; Young Adult | 2021 |
Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome.
Topics: Abortion, Spontaneous; Cabergoline; Chorionic Gonadotropin; Ergolines; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Live Birth; Ovarian Hyperstimulation Syndrome; Pregnancy; Pregnancy Rate; Pregnancy, Multiple; Randomized Controlled Trials as Topic; Withholding Treatment | 2017 |
Current Medical Strategies in the Prevention of Ovarian Hyperstimulation Syndrome
Topics: Aminoquinolines; Bromocriptine; Buserelin; Cabergoline; Chorionic Gonadotropin; Dopamine Agonists; Ergolines; Estradiol; Estrogens; Female; Fertility Agents, Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Oocyte Retrieval; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate; Progesterone; Progestins; Triptorelin Pamoate | 2017 |
Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta-analysis of randomized controlled trials.
Topics: Cabergoline; Ergolines; Female; Humans; Oocyte Retrieval; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Randomized Controlled Trials as Topic; Reproductive Techniques, Assisted | 2014 |
Prolactinomas, cabergoline, and pregnancy.
Topics: Animals; Antineoplastic Agents; Cabergoline; Ergolines; Female; Fetal Development; Humans; Hyperprolactinemia; Infertility, Female; Pituitary Neoplasms; Pregnancy; Prolactinoma | 2014 |
Update on prolactinomas. Part 2: Treatment and management strategies.
Topics: Bromocriptine; Cabergoline; Disease Management; Dopamine Agonists; Drug Administration Schedule; Drug Resistance, Neoplasm; Ergolines; Female; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neuroendoscopy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Radiosurgery; Sphenoid Sinus | 2015 |
Dopamine agonists for preventing ovarian hyperstimulation syndrome.
Topics: Abortion, Spontaneous; Administration, Oral; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Ovarian Hyperstimulation Syndrome; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Reproductive Techniques, Assisted | 2016 |
Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews.
Topics: Cabergoline; Ergolines; Female; Gonadotropin-Releasing Hormone; Humans; Metformin; Ovarian Hyperstimulation Syndrome; Pregnancy; Progesterone; Reproductive Techniques, Assisted; Review Literature as Topic | 2017 |
Clinical practice. Prolactinomas.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Visual Fields | 2010 |
Effects of cabergoline on pregnancy and embryo-fetal development: retrospective study on 103 pregnancies and a review of the literature.
Topics: Adult; Cabergoline; Cross-Sectional Studies; Dopamine Agonists; Ergolines; Female; Gestational Age; Humans; Hyperprolactinemia; Middle Aged; Pregnancy; Pregnancy Complications; Premature Birth; Prolactin; Retrospective Studies; Young Adult | 2010 |
Prolactinoma in pregnancy.
Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Fetus; Humans; Hyperprolactinemia; Infertility, Female; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma | 2011 |
Cabergoline for preventing ovarian hyperstimulation syndrome.
Topics: Abortion, Spontaneous; Administration, Oral; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Ovarian Hyperstimulation Syndrome; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Reproductive Techniques, Assisted | 2012 |
2012 update in the treatment of prolactinomas.
Topics: Cabergoline; Contraindications; Dopamine Agonists; Endocrinology; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Neurosurgical Procedures; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma | 2012 |
Contemporary management of prolactinomas.
Topics: Bromocriptine; Cabergoline; Contraindications; Diagnosis, Differential; Ergolines; Female; Humans; Hypophysectomy; Magnetic Resonance Imaging; Male; Pituitary Diseases; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Radiosurgery; Remission Induction | 2004 |
[Prolactinoma and pregnancy].
Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma | 2004 |
Hyperprolactinemia: pathophysiology and management.
Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Estrogens; Female; Humans; Hyperprolactinemia; Male; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma; Radiotherapy; Surgical Procedures, Operative | 2003 |
Current treatment issues in female hyperprolactinaemia.
Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms; Pregnancy; Prolactinoma | 2006 |
Prolactinomas and pregnancy.
Topics: Aminoquinolines; Bromocriptine; Cabergoline; Child; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma | 2005 |
A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation.
Topics: Aminoquinolines; Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Lactation; Male; Pregnancy | 1996 |
Cushing's syndrome in pregnancy treated by ketoconazole: case report and review of the literature.
Topics: Adult; Cabergoline; Cushing Syndrome; Dopamine Agonists; Ergolines; Female; Humans; Ketoconazole; Pregnancy; Pregnancy Complications; Pregnancy Outcome | 1999 |
Clinical management of prolactinomas.
Topics: Bone Density; Cabergoline; Dopamine Agonists; Drug Resistance; Ergolines; Female; Humans; Hypogonadism; Male; Pituitary Neoplasms; Pregnancy; Prolactinoma | 1999 |
Bait-delivered cabergoline for the reproductive control of the red fox (Vulpes vulpes): estimating mammalian non-target risk in south-eastern Australia.
Topics: Abortifacient Agents; Abortion, Induced; Abortion, Veterinary; Animals; Australia; Cabergoline; Embryo Implantation; Ergolines; Female; Foxes; Lactation; Mammals; Population Control; Pregnancy; Prolactin; Reproduction | 2001 |
Dopamine receptor agonists for treating prolactinomas.
Topics: Aminoquinolines; Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Ergot Alkaloids; Female; Humans; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma | 2002 |
32 trial(s) available for cabergoline and Pregnancy
| Article | Year |
|---|---|
Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Pregnancy Loss: A Randomized Controlled Trial.
Topics: Abortion, Induced; Abortion, Spontaneous; Cabergoline; Double-Blind Method; Female; Humans; Infant; Lactation; Pregnancy; Pregnancy Trimester, Second; Prolactin | 2023 |
Cabergoline versus calcium infusion in the prevention of ovarian hyperstimulation syndrome: a randomised controlled study.
Topics: Adult; Cabergoline; Calcium Gluconate; Female; Fertilization in Vitro; Humans; Incidence; Infusions, Intravenous; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate; Prospective Studies; Single-Blind Method; Treatment Outcome | 2022 |
Randomized trial of combined cabergoline and coasting in preventing ovarian hyperstimulation syndrome during in vitro fertilization/intracytoplasmic sperm injection cycles.
Topics: Adult; Cabergoline; Dopamine Agonists; Ergolines; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate; Sperm Injections, Intracytoplasmic | 2018 |
Laparoscopic ovarian drilling versus GnRH antagonist combined with cabergoline as a prophylaxis against the re-development of ovarian hyperstimulation syndrome.
Topics: Adult; Cabergoline; Chemoprevention; Clomiphene; Drug Resistance; Ergolines; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Gynecologic Surgical Procedures; Hormone Antagonists; Humans; Infertility, Female; Laparoscopy; Ovarian Hyperstimulation Syndrome; Ovary; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Secondary Prevention; Treatment Failure | 2018 |
Clinical outcome according to timing of cabergoline initiation for prevention of OHSS: a randomized controlled trial.
Topics: Adult; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Ovarian Hyperstimulation Syndrome; Pregnancy; Treatment Outcome | 2013 |
Prevention of ovarian hyperstimulation syndrome in GnRH agonist IVF cycles in moderate risk patients: randomized study comparing hydroxyethyl starch versus cabergoline and hydroxyethyl starch.
Topics: Adult; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Ergolines; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Hydroxyethyl Starch Derivatives; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Plasma Substitutes; Pregnancy; Pregnancy Rate; Prospective Studies; Secondary Prevention; Triptorelin Pamoate | 2013 |
Comparison of the effects of letrozole and cabergoline on vascular permeability, ovarian diameter, ovarian tissue VEGF levels, and blood PEDF levels, in a rat model of ovarian hyperstimulation syndrome.
Topics: Animals; Cabergoline; Capillary Permeability; Chorionic Gonadotropin; Ergolines; Eye Proteins; Female; Gonadotropins, Equine; Humans; Letrozole; Nerve Growth Factors; Nitriles; Ovarian Hyperstimulation Syndrome; Ovary; Pregnancy; Prospective Studies; Rats; Rats, Wistar; Serpins; Triazoles; Vascular Endothelial Growth Factor A | 2016 |
GnRH antagonist rescue protocol combined with cabergoline versus cabergoline alone in the prevention of ovarian hyperstimulation syndrome: a randomized controlled trial.
Topics: Adult; Antineoplastic Agents; Cabergoline; Chorionic Gonadotropin; Ergolines; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Incidence; Outcome Assessment, Health Care; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Young Adult | 2016 |
Follicular dynamics, ovulation and conception rates in bitches.
Topics: Animals; Cabergoline; Dogs; Dopamine Agonists; Ergolines; Estrous Cycle; Female; Fertilization; Gonadotropins; Male; Ovarian Follicle; Ovulation; Pregnancy | 2009 |
Effect of an injectable cabergoline formulation on serum prolactin (PRL) and milk secretion in early postpartum Beagle bitches.
Topics: Animals; Cabergoline; Dogs; Dopamine Agonists; Ergolines; Female; Lactation; Postpartum Period; Pregnancy; Prolactin; Time Factors | 2009 |
The intravaginal application of misoprostol improves induction of abortion with aglepristone.
Topics: Abortifacient Agents; Abortion, Induced; Abortion, Veterinary; Animals; Cabergoline; Cloprostenol; Dogs; Ergolines; Estrenes; Estrogens; Female; Misoprostol; Pregnancy; Progesterone; Time Factors | 2011 |
Comparison of cabergoline and intravenous albumin in the prevention of ovarian hyperstimulation syndrome: a randomized clinical trial.
Topics: Adult; Cabergoline; Dopamine Agents; Ergolines; Female; Fertilization in Vitro; Humans; Incidence; Infertility; Infusions, Intravenous; Iran; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Risk Factors; Serum Albumin; Serum Albumin, Human; Severity of Illness Index; Sperm Injections, Intracytoplasmic; Young Adult | 2012 |
Can dopamine agonist at a low dose reduce ovarian hyperstimulation syndrome in women at risk undergoing ICSI treatment cycles? A randomized controlled study.
Topics: Adult; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Ovarian Hyperstimulation Syndrome; Pregnancy; Sperm Injections, Intracytoplasmic | 2012 |
[Arrest of lactation after 2nd trimester abortion with a single dose of cabergoline in comparison with 10-day administration of teguride].
Topics: Abortion, Induced; Adolescent; Adult; Cabergoline; Drug Administration Schedule; Ergolines; Female; Humans; Lactation; Lisuride; Pregnancy; Pregnancy Trimester, Second; Prospective Studies | 2003 |
Evaluation of cabergoline and buserelin efficacy for oestrous induction in the bitch.
Topics: Administration, Oral; Animals; Buserelin; Cabergoline; Dogs; Drug Administration Schedule; Ergolines; Estrus; Female; Fertility Agents, Female; Injections, Subcutaneous; Pregnancy; Prolactin; Treatment Outcome | 2003 |
Cabergoline: a safe, easy, cheap, and effective drug for prevention/treatment of ovarian hyperstimulation syndrome?
Topics: Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Treatment Outcome | 2005 |
Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction.
Topics: Adult; Ascites; Cabergoline; Dopamine Agonists; Double-Blind Method; Ergolines; Extracellular Space; Female; Fertilization in Vitro; Granulosa Cells; Hematocrit; Hemoglobins; Humans; Image Processing, Computer-Assisted; Luteal Cells; Magnetic Resonance Imaging; Ovarian Hyperstimulation Syndrome; Ovary; Pregnancy; Prospective Studies; Receptors, Dopamine D2; Regional Blood Flow; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
Repeated induction of abortion in bitches and the effect on plasma concentrations of relaxin, progesterone and estradiol-17beta.
Topics: Abortifacient Agents; Abortion, Induced; Abortion, Veterinary; Animals; Cabergoline; Dogs; Drug Combinations; Ergolines; Estradiol; Estrenes; Female; Pregnancy; Progesterone; Relaxin | 2007 |
Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study.
Topics: Abortion, Spontaneous; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Pregnancy; Pregnancy Outcome; Prospective Studies | 2008 |
The efficacy and tolerability of long-term cabergoline therapy in hyperprolactinaemic disorders: an open, uncontrolled, multicentre study. European Multicentre Cabergoline Study Group.
Topics: Adult; Cabergoline; Dopamine Agents; Drug Administration Schedule; Ergolines; Female; Humans; Hyperprolactinemia; Pregnancy; Prospective Studies; Time Factors | 1993 |
Luteotrophic action of prolactin in dogs and the effects of a dopamine agonist, cabergoline.
Topics: Abortifacient Agents; Abortion, Induced; Animals; Cabergoline; Corpus Luteum Maintenance; Dog Diseases; Dogs; Dopamine Agents; Ergolines; Female; Fetal Resorption; Pregnancy; Pregnancy, Animal; Progesterone; Prolactin | 1993 |
Abortion induction in the cat using prostaglandin F2 alpha and a new anti-prolactinic agent, cabergoline.
Topics: Abortifacient Agents; Abortion, Induced; Animals; Cabergoline; Cats; Dinoprost; Drug Evaluation; Ergolines; Female; Fetal Resorption; Pregnancy; Pregnancy, Animal; Progesterone; Prolactin | 1993 |
Reproduction in a feral cat population and its control with a prolactin inhibitor, cabergoline.
Topics: Abortifacient Agents; Abortion, Induced; Animals; Animals, Wild; Cabergoline; Cats; Dog Diseases; Dogs; Ergolines; Female; Fertility; Male; Mammary Glands, Animal; Obstetric Labor, Premature; Pregnancy; Pregnancy, Animal; Prolactin; Reproduction | 1993 |
Effects of the dopamine agonist cabergoline in patients with prolactinoma intolerant or resistant to bromocriptine.
Topics: Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Prolactinoma | 1996 |
Use of cabergoline in the long-term treatment of hyperprolactinemic and acromegalic patients.
Topics: Acromegaly; Adenoma; Adult; Cabergoline; Dopamine Agonists; Ergolines; Female; Human Growth Hormone; Humans; Hyperprolactinemia; Insulin-Like Growth Factor I; Middle Aged; Pituitary Neoplasms; Pregnancy; Prolactin | 1997 |
[Cabergoline in the inhibition of lactogenesis and suppression of lactopoiesis].
Topics: Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Infant, Newborn; Lactation; Pregnancy; Prolactin; Puerperal Disorders | 1997 |
Cabergoline: a first-choice treatment in patients with previously untreated prolactin-secreting pituitary adenoma.
Topics: Adolescent; Adult; Antineoplastic Agents; Cabergoline; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactin; Prolactinoma; Treatment Outcome | 1999 |
Control of red fox (Vulpes vulpes) fertility with cabergoline: dose response and timing of intervention.
Topics: Abortion, Induced; Abortion, Veterinary; Animals; Animals, Newborn; Cabergoline; Dose-Response Relationship, Drug; Ergolines; Female; Foxes; Gestational Age; Lactation; Litter Size; Placebos; Pregnancy; Time Factors | 2001 |
Effectiveness of cabergoline for termination of pregnancy in silver fox (Vulpes vulpes fulva).
Topics: Abortifacient Agents; Abortion, Induced; Abortion, Veterinary; Administration, Oral; Animals; Cabergoline; Dose-Response Relationship, Drug; Ergolines; Female; Foxes; Pregnancy; Progesterone; Prolactin | 2001 |
Control of fertility in the red fox (Vulpes vulpes): effect of a single oral dose of cabergoline in early pregnancy.
Topics: Abortion, Induced; Abortion, Veterinary; Administration, Oral; Animals; Cabergoline; Dopamine Agonists; Ecosystem; Ergolines; Female; Fertility; Foxes; Litter Size; Male; Population Control; Pregnancy; Pregnancy, Animal | 2002 |
Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomised, double blind, multicentre study. European Multicentre Study Group for Cabergoline in Lactation Inhibition.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agents; Double-Blind Method; Drug Administration Schedule; Ergolines; Female; Humans; Lactation; Pregnancy; Prospective Studies | 1991 |
Prevention of puerperal lactation by a single oral administration of the new prolactin-inhibiting drug, cabergoline.
Topics: Administration, Oral; Adult; Cabergoline; Clinical Trials as Topic; Ergolines; Female; Humans; Lactation; Postpartum Period; Pregnancy; Prolactin; Random Allocation | 1988 |
89 other study(ies) available for cabergoline and Pregnancy
| Article | Year |
|---|---|
Calcium gluconate infusion is not as effective as dopamine agonists in preventing ovarian hyperstimulation syndrome.
Topics: Cabergoline; Calcium Gluconate; Dopamine Agonists; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate | 2022 |
Improving pregnancy rate in infertile patients with polycystic ovarian syndrome receiving clomiphene citrate and cabergoline in euprolactinomic women in single cycle treatment.
Topics: Cabergoline; Clomiphene; Female; Humans; Infertility, Female; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Prolactin; Prospective Studies | 2023 |
Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy.
Topics: Animals; Bromocriptine; Cabergoline; Cardiomyopathies; Dopamine Agonists; Female; Heart Failure; Mice; MicroRNAs; Myocytes, Cardiac; Peripartum Period; Pregnancy; Prolactin; Ventricular Dysfunction, Left | 2023 |
Peripartum Cardiomyopathy with the Cardiac Function Restored by Cabergoline.
Topics: Adult; Cabergoline; Cardiomyopathies; Cesarean Section; Female; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders | 2023 |
Galactorrhea: Rapid Evidence Review.
Topics: Cabergoline; Female; Galactorrhea; Humans; Hyperprolactinemia; Pituitary Neoplasms; Pregnancy; Prolactin; Thyrotropin | 2022 |
Cushing's disease in pregnancy and treatment with cabergoline: obstetric and neonatal results
Topics: Cabergoline; Colectomy; Female; Humans; Pituitary ACTH Hypersecretion; Pregnancy; Retrospective Studies; Tretinoin | 2023 |
Topics: Cabergoline; Colectomy; Female; Humans; Pituitary ACTH Hypersecretion; Pregnancy; Retrospective Studies; Tretinoin | 2023 |
Aflibercept suppresses ovarian hyperstimulation syndrome: an experimental study in rats.
Topics: Animals; Body Weight; Cabergoline; Female; Horses; Humans; Ovarian Hyperstimulation Syndrome; Pregnancy; Rats; Rats, Wistar; Vascular Endothelial Growth Factor A | 2023 |
An observational study of pregnancy and post-partum outcomes in women with prolactinoma treated with dopamine agonists.
Topics: Abortion, Spontaneous; Adenoma; Adolescent; Adult; Bromocriptine; Cabergoline; Cohort Studies; Dopamine Agonists; Female; Humans; Infertility; Lactation; Pituitary Neoplasms; Postpartum Period; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactinoma; Retrospective Studies; Young Adult | 2020 |
A Brazilian multicentre study evaluating pregnancies induced by cabergoline in patients harboring prolactinomas.
Topics: Abortion, Spontaneous; Adolescent; Adult; Aged; Cabergoline; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Middle Aged; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma; Retrospective Studies; Young Adult | 2020 |
Late-onset ovarian hyperstimulation syndrome developing during ovarian stimulation in an ectopic pregnancy: a case report.
Topics: Adult; Cabergoline; Chorionic Gonadotropin; Estradiol; Female; Fertilization in Vitro; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy, Ectopic | 2020 |
Assessing effects of dietary and milking frequency changes and injection of cabergoline during dry-off on hunger in dairy cows using 2 feed-thwarting tests.
Topics: Animal Feed; Animals; Cabergoline; Cattle; Dairying; Diet; Female; Hunger; Lactation; Milk; Pregnancy | 2021 |
Pituitary apoplexy of a giant prolactinoma during pregnancy.
Topics: Adult; Cabergoline; Cytoreduction Surgical Procedures; Fatal Outcome; Female; Humans; Infertility; Magnetic Resonance Imaging; Pituitary Apoplexy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy, Twin; Premature Birth; Prolactin; Prolactinoma | 2021 |
Combining several interventions to reduce the incidence of OHSS: A prospective cohort study.
Topics: Adult; Aspirin; Cabergoline; Chorionic Gonadotropin; Drug Therapy, Combination; Ergolines; Female; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate; Reproductive Control Agents; Severity of Illness Index | 2017 |
Pregnancy and Tumor Outcomes in Women with Prolactinoma.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Outcome Assessment, Health Care; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactinoma; Retrospective Studies; Young Adult | 2017 |
Use of cabergoline for the management of persistent Cushing's disease in pregnancy.
Topics: Adult; Antineoplastic Agents; Cabergoline; Diagnosis, Differential; Ergolines; Female; Humans; Pituitary ACTH Hypersecretion; Pregnancy; Pregnancy Complications; Prenatal Diagnosis; Recurrence; Remission Induction | 2017 |
Use of cabergoline for oestrus induction in multiparous anoestrous Beagle bitches.
Topics: Anestrus; Animals; Breeding; Cabergoline; Dogs; Ergolines; Estrus; Female; Ovulation Induction; Pregnancy; Pregnancy Rate; Progesterone | 2017 |
Lifesaving dose increment of cabergoline in life-threatening spontaneous ovarian hyperstimulation syndrome resistant to all interventions.
Topics: Adult; Cabergoline; Dopamine Agonists; Female; Humans; Ovarian Hyperstimulation Syndrome; Pregnancy; Pregnancy Complications | 2019 |
Transsphenoidal microsurgical results of female patients with prolactinomas.
Topics: Adult; Cabergoline; Cavernous Sinus; Dopamine Agonists; Endoscopy; Ergolines; Female; Humans; Magnetic Resonance Imaging; Microsurgery; Neoplasm Recurrence, Local; Neurosurgical Procedures; Pituitary Neoplasms; Postoperative Complications; Pregnancy; Prolactin; Prolactinoma; Retrospective Studies; Sphenoid Bone; Treatment Outcome | 2013 |
Combination of cabergoline and embryo cryopreservation after GnRH agonist triggering prevents OHSS in patients with extremely high estradiol levels--a retrospective study.
Topics: Adult; Cabergoline; Cryopreservation; Embryo Transfer; Ergolines; Estradiol; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Retrospective Studies; Sperm Injections, Intracytoplasmic | 2013 |
Preventing ovarian hyperstimulation syndrome: cabergoline versus coasting.
Topics: Adult; Cabergoline; Dopamine Agonists; Ergolines; Estradiol; Female; Fertility Agents, Female; Fertilization in Vitro; Follicle Stimulating Hormone; Hormones; Humans; Infertility, Female; Leuprolide; Longitudinal Studies; Ovarian Follicle; Ovarian Hyperstimulation Syndrome; Pregnancy; Pregnancy Rate; Retrospective Studies; Young Adult | 2013 |
Cabergoline therapy for Cushing disease throughout pregnancy.
Topics: Adult; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Infant, Newborn; Live Birth; Pituitary ACTH Hypersecretion; Pregnancy; Pregnancy Complications | 2013 |
Acromegaly and pregnancy: a prospective study.
Topics: Acromegaly; Adult; Cabergoline; Ergolines; Female; Human Growth Hormone; Humans; Infant, Newborn; Insulin-Like Growth Factor I; Magnetic Resonance Imaging; Octreotide; Pregnancy; Pregnancy Complications, Neoplastic; Prospective Studies; Sella Turcica | 2014 |
Relaxant effects of metoclopramide and magnesium sulfate on isolated pregnant myometrium: an in vitro study.
Topics: Adult; Cabergoline; Dopamine Agonists; Dopamine Antagonists; Ergolines; Female; Humans; In Vitro Techniques; Magnesium Sulfate; Metoclopramide; Muscle Relaxation; Myometrium; Oxytocin; Pregnancy; Tocolytic Agents; Uterine Contraction | 2014 |
Young female with acromegaloid features and pituitary macroadenoma: what is your diagnosis?
Topics: Acanthosis Nigricans; Acromegaly; Adult; Bromocriptine; Cabergoline; Diagnosis, Differential; Ergolines; Female; Gastrointestinal Diseases; Hirsutism; Human Growth Hormone; Humans; Hyperprolactinemia; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Prognathism; Prolactinoma | 2014 |
Primary anestrus due to dietary hyperthyroidism in a miniature pinscher bitch.
Topics: Administration, Oral; Anestrus; Animal Feed; Animals; Cabergoline; Diagnosis, Differential; Dog Diseases; Dogs; Ergolines; Female; Humans; Hyperthyroidism; Pedigree; Pregnancy; Pregnancy, Animal; Thyroxine | 2014 |
Treatment of maternal hypergalactia.
Topics: Adult; Breast Feeding; Breast Milk Expression; Cabergoline; Ergolines; Estrogens; Feeding Behavior; Female; Homeopathy; Humans; Infant, Newborn; Lactation Disorders; Nasal Decongestants; Pregnancy; Prolactin; Pseudoephedrine; Severity of Illness Index | 2014 |
[Use of cabergoline for prevention of ovarian hyperstimulation syndrome in assisted reproductive technologies].
Topics: Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Ovarian Hyperstimulation Syndrome; Ovary; Ovulation Induction; Pregnancy | 2014 |
[Pituitary apoplexy in a pregnant woman with cystic microprolactinoma].
Topics: Adult; Bromocriptine; Cabergoline; Combined Modality Therapy; Contraindications; Dopamine Agonists; Drug Substitution; Ergolines; Female; Headache; Hormone Replacement Therapy; Humans; Hydrocortisone; Hypophysectomy; Infant, Newborn; Male; Pituitary Apoplexy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Prolactinoma; Thyroxine; Vision Disorders | 2015 |
Cabergoline treatment for recurrent Cushing's disease during pregnancy.
Topics: Adult; Antineoplastic Agents; Biomarkers; Cabergoline; Ergolines; Female; Humans; Hydrocortisone; Live Birth; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm, Residual; Pituitary ACTH Hypersecretion; Pregnancy; Pregnancy Complications; Remission Induction; Treatment Outcome | 2016 |
Peripartum Cardiomyopathy Treatment with Dopamine Agonist and Subsequent Pregnancy with a Satisfactory Outcome.
Topics: Adolescent; Cabergoline; Cardiomyopathies; Dopamine Agonists; Ergolines; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Puerperal Disorders | 2016 |
Cabergoline in the Treatment of Peripartum Cardiomyopathy.
Topics: Cabergoline; Cardiomyopathies; Dopamine Agonists; Female; Humans; Peripartum Period; Pregnancy; Puerperal Disorders | 2016 |
Management of prolactinomas: a survey of physicians from the Middle East and North Africa.
Topics: Adult; Africa, Northern; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Middle East; Physicians; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma; Surveys and Questionnaires | 2017 |
Pregnancy and tumor outcomes in infertile women with macroprolactinoma on cabergoline therapy.
Topics: Adult; Antineoplastic Agents; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Infertility, Female; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactinoma; Treatment Outcome; Young Adult | 2017 |
Macroprolactinomas and Nonfunctioning Pituitary Adenomas and Pregnancy Outcomes.
Topics: Adenoma; Adult; Amenorrhea; Antineoplastic Agents; Bromocriptine; Cabergoline; Case-Control Studies; Cesarean Section; Dopamine Agonists; Ergolines; Female; Galactorrhea; Humans; Incidence; Pituitary Neoplasms; Pre-Eclampsia; Preconception Care; Pregnancy; Pregnancy Complications, Neoplastic; Premature Birth; Prolactinoma; Prospective Studies; Stillbirth; United Kingdom; Vision Disorders; Young Adult | 2017 |
High dose cabergoline therapy for a resistant macroprolactinoma during pregnancy.
Topics: Adult; Cabergoline; Ergolines; Female; Humans; Hyperprolactinemia; Infant, Newborn; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma | 2009 |
[Some issues in the diagnosis and treatment of hyperprolactinemia].
Topics: Aminoquinolines; Cabergoline; Diagnosis, Differential; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Pituitary Gland; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma | 2008 |
Clinical profile and long term follow up of children and adolescents with prolactinomas.
Topics: Adolescent; Amenorrhea; Bromocriptine; Cabergoline; Child; Dopamine Agonists; Ergolines; Female; Galactorrhea; Humans; Male; Pregnancy; Prolactin; Prolactinoma; Retrospective Studies; Treatment Outcome; Young Adult | 2009 |
Rapid left ventricular recovery after cabergoline treatment in a patient with peripartum cardiomyopathy.
Topics: Adult; Cabergoline; Cardiomyopathies; Echocardiography; Ergolines; Female; Humans; Natriuretic Peptide, Brain; Peptide Fragments; Pregnancy; Prolactin; Puerperal Disorders; Ventricular Dysfunction, Left | 2009 |
Recurrence of hyperprolactinemia after withdrawal of long-term cabergoline therapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Cabergoline; Ergolines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prognosis; Prolactinoma; Recurrence; Retrospective Studies; Time Factors; Withholding Treatment; Young Adult | 2009 |
An experimental model to study resistance index and systolic/diastolic ratio of uterine arteries in adverse canine pregnancy outcome.
Topics: Abortifacient Agents; Abortion, Induced; Abortion, Veterinary; Animals; Blood Pressure; Cabergoline; Cloprostenol; Dogs; Ergolines; Female; Pregnancy; Pregnancy Outcome; Pregnancy, Animal; Uterine Artery; Uterus | 2009 |
Influence of progesterone withdrawal on pregnancy-related parameters during post-implantation early pregnancy loss.
Topics: Abortion, Induced; Abortion, Veterinary; Animals; Cabergoline; Cloprostenol; Dogs; Embryonic Development; Ergolines; Estrenes; Female; Pregnancy; Pregnancy, Animal; Progesterone; Prolactin; Relaxin | 2009 |
Management of prolactinomas in Brazil: an electronic survey.
Topics: Brazil; Bromocriptine; Cabergoline; Data Collection; Dopamine Agonists; Ergolines; Female; Humans; Pregnancy; Prolactinoma | 2010 |
[Galastop].
Topics: Abortifacient Agents; Abortion, Veterinary; Animals; Cabergoline; Dogs; Ergolines; Female; Legislation, Veterinary; Netherlands; Pregnancy; Pregnancy, Animal; Ultrasonography, Prenatal | 2009 |
Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas.
Topics: Adult; Birth Weight; Bromocriptine; Cabergoline; Cohort Studies; Dopamine Agonists; Drug Resistance; Ergolines; Female; Humans; Hyperprolactinemia; Infertility, Female; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Progesterone; Prolactin; Prolactinoma | 2010 |
[Application of Pfizer drugs in the obstetrics and gynecology practice].
Topics: Anti-Bacterial Agents; Antifungal Agents; Cabergoline; Carboprost; Clindamycin; Dopamine Agonists; Drug Combinations; Ergolines; Female; Fertility Agents, Female; Fluconazole; Genital Diseases, Female; Humans; Nafarelin; Pregnancy; Pregnancy Complications; Tromethamine | 2009 |
Prevention of ovarian hyperstimulation syndrome in a rat model: efficacy comparison between cabergoline and meloxicam.
Topics: Analysis of Variance; Animals; Biopsy, Needle; Body Weight; Cabergoline; Chorionic Gonadotropin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Ergolines; Female; Immunohistochemistry; Injections, Intramuscular; Meloxicam; Organ Size; Ovarian Hyperstimulation Syndrome; Ovary; Ovulation Induction; Pregnancy; Pregnancy, Animal; Probability; Random Allocation; Rats; Rats, Wistar; Thiazines; Thiazoles; Vascular Endothelial Growth Factor A | 2010 |
Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women.
Topics: Adult; Antineoplastic Agents; Cabergoline; Case-Control Studies; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Infant, Newborn; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Prolactinoma; Retrospective Studies | 2010 |
Comparison of cabergoline and bromocriptine in patients with asymptomatic incidental hyperprolactinemia undergoing ICSI-ET.
Topics: Adult; Bromocriptine; Cabergoline; Databases, Factual; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Infertility, Female; Pregnancy; Pregnancy Rate; Retrospective Studies; Sperm Injections, Intracytoplasmic; Treatment Outcome | 2010 |
Prolactinomas and pregnancy.
Topics: Aminoquinolines; Antineoplastic Agents; Cabergoline; Dopamine Agonists; Embryonic Development; Ergolines; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactinoma | 2010 |
[Spontaneous ovarian hyperstimulation syndrome in a pregnancy with hypothyroidism].
Topics: Abdominal Pain; Adrenal Cortex Hormones; Adult; Cabergoline; Chorionic Gonadotropin; Ergolines; Female; Fibrinolytic Agents; Follicle Stimulating Hormone; Gestational Age; Graves Disease; Humans; Hypothyroidism; Luteinizing Hormone; Ovarian Hyperstimulation Syndrome; Pregnancy; Pregnancy Complications; Thyroidectomy; Thyrotropin | 2011 |
[Prolactinoma treatment status in the cabergoline era].
Topics: Adolescent; Adult; Aged; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma; Treatment Outcome | 2011 |
Comparison of the use of cabergoline and gonadotrophin to treat primary and secondary anoestrus in bitches.
Topics: Administration, Oral; Anestrus; Animals; Breeding; Cabergoline; Dogs; Dose-Response Relationship, Drug; Ergolines; Estrus; Female; Gonadotropins; Injections, Intramuscular; Ovulation Induction; Pregnancy; Pregnancy Rate | 2012 |
[Gender effect on cardiomyopathy].
Topics: Bromocriptine; Cabergoline; Cardiomyopathies; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Cardiomyopathy, Restrictive; Dopamine Agonists; Ergolines; Evidence-Based Medicine; Female; Genetic Counseling; Humans; Phenotype; Pregnancy; Pregnancy Complications, Cardiovascular; Prognosis; Prolactin; Risk Assessment; Risk Factors; Sex Factors; Treatment Outcome | 2012 |
[Postpartum psychosis associated with cabergoline].
Topics: Adult; Antipsychotic Agents; Cabergoline; Cesarean Section; Dopamine Agonists; Ergolines; Female; Hallucinations; Humans; Lactation; Postoperative Complications; Pregnancy; Pregnancy Complications; Pregnancy, Twin; Psychomotor Agitation; Psychotic Disorders; Puerperal Disorders; Risperidone; Sleep Initiation and Maintenance Disorders | 2013 |
Cabergoline therapy for macroprolactinoma during pregnancy: a case report.
Topics: Adult; Antineoplastic Agents; Cabergoline; Ergolines; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma | 2012 |
Results of a single-center observational 10-year survey study on recurrence of hyperprolactinemia after pregnancy and lactation.
Topics: Adult; Antineoplastic Agents; Breast Feeding; Cabergoline; Data Collection; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Infertility, Female; Lactation; Observation; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactinoma; Puerperal Disorders; Recurrence; Time Factors | 2013 |
Successful treatment of a large macroprolactinoma with cabergoline during pregnancy.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma | 2001 |
Assessment of cabergoline as a reproductive inhibitor in coyotes (Canis latrans).
Topics: Abortifacient Agents, Steroidal; Administration, Oral; Animals; Animals, Zoo; Cabergoline; Carnivora; Dose-Response Relationship, Drug; Drug Administration Schedule; Ergolines; Female; Litter Size; Male; Pregnancy; Progesterone; Prolactin; Time Factors | 2002 |
Induction of abortion in queens by administration of cabergoline (Galastop) solely or in combination with the PGF2alpha analogue Alfaprostol (Gabbrostim).
Topics: Abortion, Induced; Abortion, Veterinary; Animals; Cabergoline; Cats; Ergolines; Female; Pregnancy; Progesterone; Prostaglandins F; Time Factors | 2004 |
Dopamine agonist treatment before and after the birth reduces prolactin concentration but does not impair paternal responsiveness in Djungarian hamsters, Phodopus campbelli.
Topics: Animals; Bromocriptine; Cabergoline; Cricetinae; Dopamine Agonists; Ergolines; Female; Male; Parturition; Paternal Behavior; Phodopus; Pregnancy; Prolactin; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2005 |
Morphology of canine placental sites after induced embryonic or fetal death.
Topics: Animals; Cabergoline; Cloprostenol; Dogs; Embryo Loss; Ergolines; Estrenes; Female; Fetal Death; Immunohistochemistry; Microscopy, Electron, Transmission; Placenta; Pregnancy | 2006 |
[Case of juvenile parkinsonism in pregnancy].
Topics: Adult; Antiparkinson Agents; Benzothiazoles; Cabergoline; Carbidopa; Contraindications; Dopamine Agents; Dopamine Agonists; Ergolines; Family Planning Services; Female; Humans; Infant, Newborn; Levodopa; Parkinsonian Disorders; Pramipexole; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Thiazoles | 2006 |
The effects of a low dose of cabergoline on induction of estrus and pregnancy rates in anestrous bitches.
Topics: Anestrus; Animals; Breeding; Cabergoline; Dogs; Dose-Response Relationship, Drug; Ergolines; Estrus; Female; Ovulation Induction; Pregnancy; Pregnancy Rate; Pregnancy, Animal | 2007 |
Cabergoline treatment of pregnant women with macroprolactinomas.
Topics: Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactinoma; Treatment Outcome | 2007 |
Editorial: Preventing ovarian hyperstimulation syndrome.
Topics: Adult; Cabergoline; Dopamine Agonists; Ergolines; Female; Fertilization in Vitro; Humans; Ovarian Hyperstimulation Syndrome; Pregnancy; Randomized Controlled Trials as Topic; Vascular Endothelial Growth Factor A | 2007 |
Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilot study.
Topics: Adult; Cabergoline; Dopamine Agonists; Embryo Implantation; Ergolines; Female; Humans; Ovarian Hyperstimulation Syndrome; Pilot Projects; Pregnancy; Pregnancy Rate; Reproductive Techniques, Assisted; Retrospective Studies | 2007 |
Cabergoline: an advance in dopaminergic therapy.
Topics: Cabergoline; Dopamine Agents; Ergolines; Female; Humans; Hyperprolactinemia; Patient Compliance; Pregnancy; Prolactin | 1994 |
Cabergoline treated hyperprolactinaemia results in pregnancy in a bromocriptine intolerant patient after seventeen years of infertility.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agents; Ergolines; Female; Humans; Hyperprolactinemia; Infertility, Female; Pregnancy | 1994 |
Effectiveness of cabergoline in reducing follicle-stimulating hormone and prolactin hypersecretion from pituitary macroadenoma in an infertile woman.
Topics: Adenoma; Adult; Amenorrhea; Cabergoline; Dopamine Agonists; Ergolines; Female; Follicle Stimulating Hormone; Humans; Infertility, Female; Pituitary Neoplasms; Pregnancy; Prolactin | 1994 |
Regulation of progesterone during pregnancy in the cat: studies on the roles of corpora lutea, placenta and prolactin secretion.
Topics: Animals; Cabergoline; Cats; Corpus Luteum; Ergolines; Female; Megestrol; Megestrol Acetate; Ovariectomy; Placenta; Pregnancy; Pregnancy, Animal; Progesterone; Prolactin; Pseudopregnancy | 1993 |
Practical use of a combination of a dopamine agonist and a synthetic prostaglandin analogue to terminate unwanted pregnancy in dogs.
Topics: Abortion, Induced; Abortion, Veterinary; Administration, Oral; Animals; Cabergoline; Cloprostenol; Dogs; Dopamine Agonists; Drug Therapy, Combination; Ergolines; Female; Injections, Subcutaneous; Pregnancy; Pregnancy Outcome; Progesterone | 1996 |
In vivo investigation of luteal function in dogs: effects of cabergoline, a dopamine agonist, and prolactin on progesterone secretion during mid-pregnancy and -diestrus.
Topics: Animals; Cabergoline; Corpus Luteum; Diestrus; Dogs; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Female; Injections, Intravenous; Injections, Subcutaneous; Luteal Phase; Luteinizing Hormone; Pregnancy; Pregnancy, Animal; Progesterone; Prolactin; Radioimmunoassay; Random Allocation; Time Factors | 1997 |
Prevention and termination of pregnancy in rats by cabergoline, a dopamine agonist.
Topics: Animals; Cabergoline; Contraceptive Agents, Female; Dopamine Agonists; Embryo Implantation; Ergolines; Estradiol; Female; Male; Pregnancy; Pregnancy, Animal; Progesterone; Prolactin; Rats; Rats, Sprague-Dawley | 1997 |
Termination of dioestrus and induction of oestrus in dioestrous nonpregnant bitches by the prolactin antagonist cabergoline.
Topics: Animals; Breeding; Cabergoline; Diestrus; Dogs; Dopamine Agonists; Ergolines; Estrus; Female; Infertility, Female; Pregnancy; Progesterone; Prolactin; Uterus; Vaginal Smears | 1997 |
Termination of pregnancy in cats using a combination of cabergoline, a new dopamine agonist, and a synthetic PGF2 alpha, cloprostenol.
Topics: Abortion, Induced; Administration, Oral; Animals; Cabergoline; Cats; Cloprostenol; Dopamine Agonists; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Female; Injections, Subcutaneous; Pregnancy; Progesterone | 1997 |
Long-term treatment with cabergoline, a new long-lasting ergoline derivate, in idiopathic or tumorous hyperprolactinaemia and outcome of drug-induced pregnancy.
Topics: Adenoma; Adolescent; Adult; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Kinetics; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactin | 1997 |
[Administration of combination therapy with synthetic pgf2alpha analogs and a dopamine agonist for the termination of unwanted pregnancy in pregnant dogs. A study of six cases].
Topics: Abortifacient Agents; Abortion, Induced; Animals; Cabergoline; Cloprostenol; Dinoprost; Dogs; Dopamine Agonists; Drug Therapy, Combination; Ergolines; Female; Injections, Subcutaneous; Pregnancy | 1998 |
Effects of cabergoline on reproduction in three families of Australian marsupials.
Topics: Administration, Oral; Animals; Animals, Newborn; Body Weight; Cabergoline; Dopamine Agonists; Ergolines; Female; Injections, Intramuscular; Lactation; Macropodidae; Marsupialia; Pregnancy; Pregnancy, Animal; Prolactin; Reproduction | 1998 |
[Cabergoline].
Topics: Antiparkinson Agents; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Pregnancy; Prolactin | 1998 |
Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients.
Topics: Adenoma; Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance; Drug Tolerance; Ergolines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Retrospective Studies; Sex Characteristics | 1999 |
Dopamine agonist therapy in hyperprolactinemia.
Topics: Aminoquinolines; Cabergoline; Dopamine Agonists; Drug Administration Schedule; Ergolines; Female; Humans; Hyperprolactinemia; Male; Pregnancy; Pregnancy Complications | 1999 |
Effect of stage of anestrus on the induction of estrus by the dopamine agonist cabergoline in dogs.
Topics: Anestrus; Animals; Behavior, Animal; Cabergoline; Dogs; Dopamine Agonists; Ergolines; Estradiol; Female; Fertility; Luteinizing Hormone; Male; Pregnancy; Progesterone; Prolactin; Vagina | 1999 |
Cabergoline.
Topics: Animals; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Pregnancy | 2000 |
Cabergoline influences ovarian stimulation in hyperprolactinaemic patients with polycystic ovary syndrome.
Topics: Adult; Cabergoline; Chorionic Gonadotropin; Dopamine Agonists; Ergolines; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Infertility, Female; Ovarian Follicle; Ovarian Hyperstimulation Syndrome; Ovary; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Recombinant Proteins; Time Factors; Ultrasonography | 2001 |
[Dostinex - the most effective medicine for inhibition of postpartal lactation].
Topics: Cabergoline; Dopamine Agents; Drug Administration Schedule; Ergolines; Female; Humans; Lactation; Pregnancy; Prolactin | 2001 |
Use of cabergoline to treat primary and secondary anestrus in dogs.
Topics: Anestrus; Animals; Cabergoline; Dogs; Dopamine Agonists; Ergolines; Female; Fertility; Ovarian Follicle; Ovulation Induction; Pregnancy; Progesterone; Prospective Studies; Safety; Treatment Outcome; Vagina; Vaginal Smears | 2002 |
Effects on pseudopregnancy, pregnancy and interoestrous intervals of pharmacological suppression of prolactin secretion in female dogs and cats.
Topics: Abortion, Spontaneous; Animals; Birth Weight; Cabergoline; Cats; Dogs; Dose-Response Relationship, Drug; Ergolines; Estrus; Female; Lactation; Pregnancy; Pregnancy, Animal; Progesterone; Prolactin; Pseudopregnancy | 1989 |
Dose-related prolactin inhibitory effect of the new long-acting dopamine receptor agonist cabergoline in normal cycling, puerperal, and hyperprolactinemic women.
Topics: Administration, Oral; Adolescent; Adult; Aged; Cabergoline; Delayed-Action Preparations; Dose-Response Relationship, Drug; Ergolines; Female; Humans; Hyperprolactinemia; Menstrual Cycle; Middle Aged; Postpartum Period; Pregnancy; Prolactin; Receptors, Dopamine | 1987 |